Concepedia

Pragya Chandrakar

PC

Statistics

Publications

12

Citations

335

H-Index

11

Active since

2016

Affiliations

Central Drug Research Institute(Current)

Academy of Scientific and Innovative Research

Council of Scientific and Industrial Research

Brigham and Women's Hospital

Harvard University

Pragya Chandrakar is an author at Central Drug Research Institute specializing in leishmaniasis pathogenesis, visceral leishmaniasis, and infectious diseases.

ORCID

Publications per year

2016–2025

12

Publications

12

Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis

Akanksha Upadhyay, Pragya Chandrakar, Sampa Gupta et al. · Journal of Medicinal Chemistry · 2019 · 60 citations

, , +17

<i>Leishmania donovani</i> Subverts Host Immune Response by Epigenetic Reprogramming of Macrophage M(Lipopolysaccharides + IFN-γ)/M(IL-10) Polarization

N. Parmar, Pragya Chandrakar, S.K. Kar · The Journal of Immunology · 2020 · 47 citations

, , +17

Ammonium trichloro [1,2-ethanediolato-O,O′]-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway

Preeti Vishwakarma, N. Parmar, Pragya Chandrakar et al. · Cellular and Molecular Life Sciences · 2017 · 42 citations · Full text

, , +17

Stepwise differentiation of follicular helper T cells reveals distinct developmental and functional states

Manuel Alfredo Podestà, Cecília B. Cavazzoni, Benjamin L. Hanson et al. · Nature Communications · 2023 · 41 citations · Full text

, , +17

<i>Leishmania donovani</i> Exploits Tollip, a Multitasking Protein, To Impair TLR/IL-1R Signaling for Its Survival in the Host

N. Parmar, Pragya Chandrakar, Preeti Vishwakarma et al. · The Journal of Immunology · 2018 · 37 citations · Full text

, , +17

1–5 of 12